1. |
Sirven JI. Epilepsy:aspectrum disorder. Cold Spring Harbor Perspectives in Medicine, 2015, 5(9):a022848.
|
2. |
Berg AT, Kabir AA, Liferidge AT, et al. Revised terminology and concepts for organization of seizures and epilepsies:report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia, 2010, 51(4):676-685.
|
3. |
Fisher RS, Martello JP, Kanner AM, et al. ILAE Official Report:A practical clinical definition of epilepsy. Epilepsia, 2014, 55(4):475-482.
|
4. |
中华医学会, 临床诊疗指南癫痫病分册.北京:人民卫生出版社. 2015.
|
5. |
Wang WZ, Shinnar S, Hopp JL, et al. The prevalence and treatment gap in epilepsy in China:an ILAE/IBE/WHO study. Neurology, 2003, 60(9):1544-1545.
|
6. |
Gu L, French JA. Prevalence of epilepsy in the People's Republic of China:A systematic review. Epilepsy Research, 2013, 105(1-2):195-205.
|
7. |
Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. Handbook of Clinical Neurology, 2012, 107(5):113-133.
|
8. |
Phenome E, Epi KC. De novo mutations in epileptic encephalopathies. Nature, 2013, 501(7466):217-221.
|
9. |
Truccolo W, Gloss DS, Sanchez AM, et al. Single-neuron dynamics in human focal epilepsy. Nat Neurosci, 2011, 14(5):635-641.
|
10. |
Leach JP, Abassi H. Modern management of epilepsy. Clin Med, 2013, 13(1):84-86.
|
11. |
Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ, 2014, 348(254):10.1136.
|
12. |
Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline:Management of an unprovoked first seizure in adults:Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2015, 84(16):1705.
|
13. |
National Institute for Health and Clinical Excellence (NICE). The epilepsies:the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London (UK):National Institute for Health and Clinical Excellence (NICE); 2012 Jan. 117 p. (Clinical guideline; no. 137).
|
14. |
中华医学会.临床诊疗指南癫痫病分册.北京:人民卫生出版社. 2007.
|
15. |
Hesdorffer DC, Rossjohn J, Mc Cluskey J, et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia, 2009, 50(5):1102-1108.
|
16. |
Illing PT, Vivian JP, Purcell AW, et al. Human leukocyte antigen-associated drug hypersensitivity. Current Opinion in Immunology, 2013, 25(1):81-89.
|
17. |
Gilad R, Diaz-Arrastia R. Management of seizures following a stroke:what are the options?. Drugs Aging, 2012, 29(7):533-538.
|
18. |
Guekht A, Bornstein NM. Seizures after stroke. Handb Clin Neurol, 2012, 10(8):569-583.
|
19. |
Marigold R, Mickey B, D'Ambrosio R, et al. Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage. Cochrane Database Syst Rev, 2013, 6(2):CD008710.
|
20. |
Guo J, Li J, Zhou M, et al. Statin treatment reduces the risk of poststroke seizures. Neurology, 2015, 85(8):701-707.
|
21. |
Annegers JF, Yablon S, Madden C, et al. A population-based study of seizures after traumatic brain injuries. New England Journal of Medicine, 1998, 338(1):20-24.
|
22. |
Szaflarski JP, Nazzal Y, Dreer LE. Post-traumatic epilepsy:current and emerging treatment options. Neuropsychiatr Dis Treat, 2014, 10(2):1469-77.
|
23. |
魏俊吉.神经外科重症管理专家共识(2013版).中国脑血管病杂志, 2013, 10(8):1765-1779.
|
24. |
Bhullar IS, Agostini MA, Van Ness PC, et al. More harm than good:antiseizure prophylaxis after traumatic brain injury does not decrease seizure rates but may inhibit functional recovery. Journal of Trauma and Acute Care Surgery, 2014, 76(1):54-61.
|
25. |
Gupta PK, Sayed N, Ding K, et al. Subtypes of post-traumatic epilepsy:clinical, electrophysiological, and imaging features. J Neurotrauma, 2014, 31(16):1439-1443.
|
26. |
Sayegh ET, Althouse SK, Miller JC, et al. Anticonvulsant prophylaxis for brain tumor surgery:determining the current best available evidence. J Neurosurg, 2014, 121(5):1139-1147.
|
27. |
Ansari SF, Bohnstedt BN, Perkins SM, et al. Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resections. J Neurooncol, 2014, 118(1):117-122.
|
28. |
Iuchi T, Eadie M, Roten A, et al. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours:a phase Ⅱ prospective, randomised study. J Neurol Neurosurg Psychiatry, 2015, 86(10):1158-1162.
|
29. |
Skardelly M, Lander CM, O'Brien TJ, et al. Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors:A retrospective observational single center study. Ann Neurol, 2015, 78(6):917-928.
|
30. |
Vajda FJ, Graham J, Roten A, et al. Teratogenicity of the newer antiepileptic drugs——the Australian experience. J Clin Neurosci, 2012, 19(1):57-59.
|
31. |
Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol, 1985, 152(5):499-504.
|
32. |
EURAP Study Group. Seizure control and treatment in pregnancy:observations from the EURAP epilepsy pregnancy registry. Neurology, 2006, 66(3):354-560.
|
33. |
Meador KJ, Thompson L, Williams M, et al. Breastfeeding in children of women taking antiepileptic drugs:cognitive outcomes at age 6 years. JAMA Pediatr, 2014, 168(8):729-736.
|
34. |
Go CY, Abdelmoity A, Buchhalter J, et al. Evidence-based guideline update:medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology, 2012, 78(24):1974-1980.
|
35. |
Kayyali HR, Gustafson M, Myers T, et al. Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Pediatr Neurol, 2014, 50(3):224-247.
|
36. |
Morris GL, Buchhalter J, Gonzalez G, et al., Evidence-based guideline update:vagus nerve stimulation for the treatment of epilepsy:report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 2013, 81(16):297-303.
|
37. |
Sullivan R, Yao R, Jarrar R, et al. Text lassification towards detecting misdiagnosis of an epilepsy syndrome in a pediatric population. in annual symposium proceedings/AMIA symposium. AMIA Symposium, 2014, 14(11):1082-1087.
|
38. |
Liu J, Liu Z, Chen T, et al. Treatment of epilepsy in China:Formal or informal. Neural Regen Res, 2013, 8(35):3316-3324.
|
39. |
Hu J, Zhu S, Sander JW, et al. Prevalence and treatment gap of active convulsive epilepsy:a large community-based survey in rural west China. Seizure, 2014, 23(5):333-337.
|
40. |
Huang DH, Ru X, Zheng J, et al. Treatment gaps of epilepsy and retention rates of sodium valproate in rural Guangxi, China. Genetics & Molecular Research Gmr, 2014, 13(3):6202-6212.
|
41. |
Wang W, Wu J, Li S, et al. Sodium valproate for epilepsy in rural China:an efficacy and safety assessment in primary care. Epilepsy Res, 2012, 102(3):201-205.
|